INTRA CELLULAR THERAPIES INC has a total of 567 patent applications. It decreased the IP activity by 4.0%. Its first patent ever was published in 2006. It filed its patents most often in WIPO (World Intellectual Property Organization), United States and EPO (European Patent Office). Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and basic materials chemistry are ATOPIX THERAPEUTICS LTD, GENKYOTEX SUISSE SA and AZEVAN PHARMACEUTICALS INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | WIPO (World Intellectual Property Organization) | 93 | |
#2 | United States | 84 | |
#3 | EPO (European Patent Office) | 70 | |
#4 | Australia | 49 | |
#5 | China | 42 | |
#6 | Republic of Korea | 38 | |
#7 | Canada | 34 | |
#8 | Israel | 30 | |
#9 | Japan | 26 | |
#10 | Mexico | 21 | |
#11 | Brazil | 15 | |
#12 | Colombia | 6 | |
#13 | Costa Rica | 6 | |
#14 | Dominican Republic | 6 | |
#15 | Hong Kong | 6 | |
#16 | Morocco | 6 | |
#17 | Peru | 6 | |
#18 | Singapore | 6 | |
#19 | Tunisia | 6 | |
#20 | Russian Federation | 5 | |
#21 | Taiwan | 4 | |
#22 | Chile | 2 | |
#23 | India | 2 | |
#24 | Uruguay | 2 | |
#25 | Argentina | 1 | |
#26 | New Zealand | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry | |
#3 | Basic materials chemistry | |
#4 | Measurement | |
#5 | Environmental technology | |
#6 | Biotechnology |
# | Name | Total Patents |
---|---|---|
#1 | Li Peng | 398 |
#2 | Wennogle Lawrence P | 267 |
#3 | Davis Robert | 152 |
#4 | Zhao Jun | 101 |
#5 | Mates Sharon | 96 |
#6 | Zheng Hailin | 72 |
#7 | Zhang Qiang | 66 |
#8 | Yao Wei | 59 |
#9 | Snyder Gretchen | 47 |
#10 | Wennogle Lawrence | 47 |
Publication | Filing date | Title |
---|---|---|
WO2021062307A1 | Novel methods | |
WO2021046179A1 | Novel compounds | |
WO2021046250A1 | Methods of treatment | |
WO2021035157A1 | Organic compounds | |
US2021000822A1 | Novel methods | |
WO2020210614A1 | Organic compounds | |
WO2020206391A1 | Methods of treating neuropathic pain | |
WO2020154519A2 | Methods of treating addiction | |
WO2020146384A1 | Organic compounds | |
WO2020132605A1 | Organic compounds | |
WO2020132474A1 | Organic compound | |
WO2020131911A1 | Substituted heterocycle fused gamma-carbolines synthesis | |
WO2020131899A1 | Organic compound | |
WO2020131918A1 | Organic compounds | |
WO2020131895A1 | Substituted heterocycle fused gamma-carbolines synthesis | |
WO2020123952A1 | Amorphous solid dispersions | |
WO2020086650A2 | Novel compounds | |
WO2020086481A1 | Novel uses | |
WO2020069043A1 | Novel uses | |
WO2020047408A1 | Novel methods |